Sheetal ✍ शीतल ✍ شیتل(@ssoniisshh1) 's Twitter Profile Photo

Starting oral chemotherapy for TNBC from today. Course of treatment 6 months. If you see any weird or funny or odd tweets from this account, it is the side effect of the meds and not me. 😌

Starting oral chemotherapy for TNBC from today. Course of treatment 6 months. If you see any weird or funny or odd tweets from this account, it is the side effect of the meds and not me. 😌
account_circle
selena jane kearns 🇺🇦. SJ(@JaneSelena) 's Twitter Profile Photo

Yesterday marked the half way point 😁 12th weekly treatments completed. Didn't have to miss one even though bloods were borderline few times 💪. Next wk start the dreaded 'red devil' for 3mths. Definitely not looking forward to it but on we go.

Yesterday marked the half way point 😁 12th weekly treatments completed. Didn't have to miss one even though bloods were borderline few times 💪. Next wk start the dreaded 'red devil' for 3mths. Definitely not looking forward to it but on we go. #tnbc #breastcancerresearch
account_circle
CURRENTLY STARRING by The Rant(@csbytherant) 's Twitter Profile Photo

CURRENTLY STARRING presents its first ever online 'Feature File' for May 2024. The list brings together a dynamic column of cinema, curated by TNBC members for it's first time online.

Editor in Chief, S.A.M and the TNBC Creators HUB collaborated on a teaser for the 'Feature…

account_circle
Yakup Ergün(@dr_yakupergun) 's Twitter Profile Photo

💥ER-low BC, if possible, should be assessed for endocrine sensitivity (luminal type) through molecular profiling.
If not feasible, it would be appropriate not to deprive these patients of innovative treatments such as IO by considering them similar to TNBC…

💥ER-low BC, if possible, should be assessed for endocrine sensitivity (luminal type) through molecular profiling. 
If not feasible, it would be appropriate not to deprive these patients of innovative treatments such as IO by considering them similar to TNBC…
account_circle
Breast Cancer Now(@BreastCancerNow) 's Twitter Profile Photo

“Triple negative breast cancer awareness day is so important because TNBC needs so much more. More research and clinical trials, more treatment options and more funding.” - Carly

account_circle
P. Wilson(@PWilsonDMK) 's Twitter Profile Photo

When we met Most Rev. George Antonysamy, Archbishop of Madras - Mylapore, President of Tamil Nadu Bishop's Council (TNBC) and Tamil Nadu Latin Bishop's Council (TNLBC) with Hon'ble Mr. P.K. Sekar Babu, Hon'ble Mr. Ma. Subramaniam, Hon'ble MPs Mr. Dayanidhi Maran, Mrs. Thamizhachi…

When we met Most Rev. George Antonysamy, Archbishop of Madras - Mylapore, President of Tamil Nadu Bishop's Council (TNBC) and Tamil Nadu Latin Bishop's Council (TNLBC) with Hon'ble Mr. P.K. Sekar Babu, Hon'ble Mr. Ma. Subramaniam, Hon'ble MPs Mr. Dayanidhi Maran, Mrs. Thamizhachi…
account_circle
Yakup Ergün(@dr_yakupergun) 's Twitter Profile Photo

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and TNBC: TROPION-PanTumor01 Study

🔍85 pts, heavily pretreated

HR+/HER2- and TNBC
ORR➡️27% and 32%
PFS➡️8.3 and 4.8 mo
OS➡️ NR and 13.5 mo

ILD➡️1 pts
No treatment-related deaths

OncoAlert
ascopubs.org/doi/10.1200/JC…

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and TNBC:  TROPION-PanTumor01 Study 

🔍85 pts, heavily pretreated

HR+/HER2- and TNBC
ORR➡️27% and 32%
PFS➡️8.3 and 4.8 mo
OS➡️ NR and 13.5 mo

ILD➡️1 pts
No treatment-related deaths

@OncoAlert
 ascopubs.org/doi/10.1200/JC…
account_circle
Top Biomedical Science(@imedverse) 's Twitter Profile Photo

In patients with heavily pretreated advanced HR+/HER2– BC and TNBC, Dato-DXd demonstrated promising clinical activity and a manageable safety profile. Journal of Clinical Oncology

In patients with heavily pretreated advanced HR+/HER2– BC and TNBC, Dato-DXd demonstrated promising clinical activity and a manageable safety profile. @JCO_ASCO #Oncology #breastCancer
account_circle